動物用抗生物質・抗菌剤のグローバル市場予測(~2027年)

◆英語タイトル:Animal Antibiotics & Antimicrobials Market Research Report by Product, Mode of Delivery, Type of Animal, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

360iResearchが発行した調査報告書(360iR22DC239)◆商品コード:360iR22DC239
◆発行会社(リサーチ会社):360iResearch
◆発行日:2022年10月
◆ページ数:236
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single UserUSD4,949 ⇒換算¥732,452見積依頼/購入/質問フォーム
Enterprise LicenseUSD9,949 ⇒換算¥1,472,452見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

360iResearch社の本調査報告書では、2021年に4,716.36百万ドルであった世界の動物用抗生物質・抗菌剤市場規模が、2022年に4,931.48百万ドルになり、2027年まで年平均4.73%で成長して6,226.38百万ドルに達すると予測しています。本報告書では、動物用抗生物質・抗菌剤の世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別(アミノグリコシド系、セファロスポリン系、フルオロキノロン系、リンコサミド系、マクロライド系)分析、投与方法別(注射剤、経口粉末剤、経口液剤、プレミックス)分析、動物種類別(伴侶動物、食用動物)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報など、以下の項目を掲載しています。本書に記載されている企業情報としては、Bayer AG、Boehringer Ingelheim GmbH、Ceva Sante Animale、Dechra Pharmaceuticals PLC、Eli Lilly and Company、Merck&Co., Inc.、Sanofi、Vetoquinol S.A.、Virbac、Zoetis, Inc.などが含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト

・世界の動物用抗生物質・抗菌剤市場規模:製品別
- アミノグリコシドの市場規模
- セファロスポリンの市場規模
- フルオロキノロンの市場規模
- リンコサミドの市場規模
- マクロライドの市場規模

・世界の動物用抗生物質・抗菌剤市場規模:投与方法別
- 注射剤の市場規模
- 経口粉末剤の市場規模
- 経口液剤の市場規模
- プレミックスの市場規模

・世界の動物用抗生物質・抗菌剤市場規模:動物種類別
- 伴侶動物における市場規模
- 食用動物における市場規模

・世界の動物用抗生物質・抗菌剤市場規模:地域別
- 南北アメリカの動物用抗生物質・抗菌剤市場規模
アメリカの動物用抗生物質・抗菌剤市場規模
カナダの動物用抗生物質・抗菌剤市場規模
ブラジルの動物用抗生物質・抗菌剤市場規模

- アジア太平洋の動物用抗生物質・抗菌剤市場規模
日本の動物用抗生物質・抗菌剤市場規模
中国の動物用抗生物質・抗菌剤市場規模
インドの動物用抗生物質・抗菌剤市場規模
韓国の動物用抗生物質・抗菌剤市場規模
台湾の動物用抗生物質・抗菌剤市場規模

- ヨーロッパ/中東/アフリカの動物用抗生物質・抗菌剤市場規模
イギリスの動物用抗生物質・抗菌剤市場規模
ドイツの動物用抗生物質・抗菌剤市場規模
フランスの動物用抗生物質・抗菌剤市場規模
ロシアの動物用抗生物質・抗菌剤市場規模

- その他地域の動物用抗生物質・抗菌剤市場規模

・競争状況
・企業情報

The Global Animal Antibiotics & Antimicrobials Market size was estimated at USD 4,716.36 million in 2021 and expected to reach USD 4,931.48 million in 2022, and is projected to grow at a CAGR 4.73% to reach USD 6,226.38 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Animal Antibiotics & Antimicrobials to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Aminoglycosides, Cephalosporins, Fluoroquinolones, Lincosamides, Macrolides, Penicillins, Sulfonamides, and Tetracyclines.

Based on Mode of Delivery, the market was studied across Injections, Oral Powders, Oral Solutions, and Premixes.

Based on Type of Animal, the market was studied across Companion Animals and Food-Producing Animals. The Companion Animals is further studied across Cats, Dogs, and Horses. The Food-Producing Animals is further studied across Cattle, Pigs, Poultry, and Sheep and Goats.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Animal Antibiotics & Antimicrobials market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Animal Antibiotics & Antimicrobials Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Animal Antibiotics & Antimicrobials Market, including Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Eli Lilly and Company, Merck & Co., Inc., Sanofi, Vetoquinol S.A., Virbac, and Zoetis, Inc..

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Animal Antibiotics & Antimicrobials Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Animal Antibiotics & Antimicrobials Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Animal Antibiotics & Antimicrobials Market?
4. What is the competitive strategic window for opportunities in the Global Animal Antibiotics & Antimicrobials Market?
5. What are the technology trends and regulatory frameworks in the Global Animal Antibiotics & Antimicrobials Market?
6. What is the market share of the leading vendors in the Global Animal Antibiotics & Antimicrobials Market?
7. What modes and strategic moves are considered suitable for entering the Global Animal Antibiotics & Antimicrobials Market?

❖ レポートの目次 ❖

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising demand for livestock products
5.1.1.2. Strong demand for penicillin based antibiotics
5.1.1.3. Increasing awareness and initiatives concerning animal health and welfare
5.1.1.4. Regulations for preventing the spread of animal diseases
5.1.2. Restraints
5.1.2.1. Increasing resistance to antibiotic
5.1.3. Opportunities
5.1.3.1. Increasing in companion animal numbers
5.1.3.2. Initiatives to develop novel technologies
5.1.4. Challenges
5.1.4.1. Cheaper substitutes available in the market
5.2. Cumulative Impact of COVID-19

6. Animal Antibiotics & Antimicrobials Market, by Product
6.1. Introduction
6.2. Aminoglycosides
6.3. Cephalosporins
6.4. Fluoroquinolones
6.5. Lincosamides
6.6. Macrolides
6.7. Penicillins
6.8. Sulfonamides
6.9. Tetracyclines

7. Animal Antibiotics & Antimicrobials Market, by Mode of Delivery
7.1. Introduction
7.2. Injections
7.3. Oral Powders
7.4. Oral Solutions
7.5. Premixes

8. Animal Antibiotics & Antimicrobials Market, by Type of Animal
8.1. Introduction
8.2. Companion Animals
8.3.1. Cats
8.3.2. Dogs
8.3.3. Horses
8.3. Food-Producing Animals
8.4.1. Cattle
8.4.2. Pigs
8.4.3. Poultry
8.4.4. Sheep and Goats

9. Americas Animal Antibiotics & Antimicrobials Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Animal Antibiotics & Antimicrobials Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Animal Antibiotics & Antimicrobials Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Bayer AG
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Boehringer Ingelheim GmbH
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Ceva Sante Animale
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Dechra Pharmaceuticals PLC
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Eli Lilly and Company
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Merck & Co., Inc.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Sanofi
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Vetoquinol S.A.
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Virbac
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Zoetis, Inc.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 動物用抗生物質・抗菌剤のグローバル市場予測(~2027年)(Animal Antibiotics & Antimicrobials Market Research Report by Product, Mode of Delivery, Type of Animal, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆